Pfizer
Tolani O. is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as the VP and Head of the Oncology Unit Management Office at Pfizer since January 2024. Prior to this role, Tolani held the position of Head of Vendor Strategy Management at Seagen from January 2019 to December 2023. Tolani's career at Sanofi spanned nearly 15 years, encompassing a range of leadership roles including Global Procurement Partnerships Excellence Head and Global Scientific & Clinical Procurement Operations Head, among others. Initial career experience includes positions as Clinical Data Manager at Nabi Biopharmaceuticals and Senior Clinical Data Manager at Chiltern International Inc. Tolani holds a BSc (Hons) in Pharmacology from The University of Sheffield, completed between 1994 and 1997.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.